Health Wire Burundi: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Burundi.

Press releases published on March 25, 2026

Mar. 25, 2026

HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

Indeterminate GlobeNewswire

Mar. 25, 2026

BeyondSpring Reports 2025 Year-End Financial Results

Indeterminate GlobeNewswire

Mar. 25, 2026

Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48

Indeterminate GlobeNewswire

Mar. 25, 2026

TOMI Environmental Solutions’ Binary Ionization Technology Approved in the Netherlands

Indeterminate GlobeNewswire

Mar. 25, 2026

IMUNON Reports Updated Phase 2 Data Showing Continued Improvement in Median Overall Survival with IMNN-001 in Women with Newly Diagnosed Advanced Ovarian Cancer

Indeterminate GlobeNewswire

Mar. 25, 2026

ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026

Indeterminate GlobeNewswire

Mar. 25, 2026

Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”

Indeterminate GlobeNewswire

Mar. 25, 2026

ORYZON Strengthens Vafidemstat Patent Portfolio With U.S. Notice of Allowance

Indeterminate GlobeNewswire

Mar. 25, 2026

LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia

Indeterminate GlobeNewswire

Mar. 25, 2026

Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research

Indeterminate GlobeNewswire

Mar. 25, 2026

Avalyn Announces Publication Demonstrating Correlation Between Imaging, Improved Lung Function, and Quality of Life with AP01 in Patients with Idiopathic Pulmonary Fibrosis

Indeterminate GlobeNewswire

Mar. 25, 2026

AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program

Indeterminate GlobeNewswire

Mar. 25, 2026

ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights

Indeterminate GlobeNewswire

Mar. 25, 2026

Flyte Hops: Vision Jet Platform Seeks to Redefine Private Aviation

Indeterminate GlobeNewswire

Mar. 25, 2026

CDT Equity Inc. Announces Reverse Stock Split

Indeterminate GlobeNewswire

Mar. 25, 2026

Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength

Indeterminate GlobeNewswire

Mar. 25, 2026

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204

Indeterminate GlobeNewswire

Mar. 25, 2026

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

Indeterminate GlobeNewswire

Mar. 25, 2026

Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer

Indeterminate GlobeNewswire

Mar. 25, 2026

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

Indeterminate GlobeNewswire